ESC 365
Menu
Home
Search
Live & Upcoming Events
About
Create an account
Sign in
Back
Open Access
Management of Arrhythmias in Cardiac Dysfunction Patients: ESC Guidelines Update & New Approaches with Landiolol
Event:
Heart Failure 2021 Online Congress
Topic:
Pharmacotherapy
Session type:
Satellite Symposium
Sponsored by AOP Orphan Pharmaceuticals AG
Date:
1 July 2021
Time:
11:20 - 12:05
Session
This content is currently on OPEN ACCESS
Sign in to view the resources
0
5
presentations
in this session
Welcome and introduction.
Access
Video
0
Intravenous landiolol, a novel β (1)-adrenergic blocker for patients with cardiac dysfunction and atrial fibrillation.
Speaker:
Professor H. Puererfellner (Linz, AT)
Access
Video
0
Questions and answers.
Access
0
Management of Atrial Fibrillation in patients with cardiac dysfunction. The 2020 ESC Guidelines and the addition of Landiolol.
Speaker:
Professor Z. Fras (Ljubljana, SI)
Access
Video
0
Questions & answers.
Access
0
2
speakers
from this session
Professor Helmut Puererfellner
Ordensklinikum Linz Elisabethinen, Linz (Austria)
16
presentations
0
follower
Professor Zlatko Fras
University Medical Centre of Ljubljana, Ljubljana (Slovenia)
11
presentations
0
follower
This platform is supported by